Open access
Oct 2026
Multi-omics-driven personalized management of advanced HCC.
Hepatocellular carcinoma (HCC) management is challenging due to its complex tumor microenvironment and poor treatment responses. Here, using tumor specimens from a prospective clinical trial of combined transarterial chemoembolization (TACE) with immune checkpoint blockade (ICB), we perform exhaustive multi-omics analy...
Jian-Peng Sheng, Jin-Yuan Song, Lin Wang et al.
· Cell Reports Medicine · 0 citations